"Leishmaniasis, Visceral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Descriptor ID |
D007898
|
| MeSH Number(s) |
C03.752.300.500.510
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Leishmaniasis, Visceral".
Below are MeSH descriptors whose meaning is more specific than "Leishmaniasis, Visceral".
This graph shows the total number of publications written about "Leishmaniasis, Visceral" by people in this website by year, and whether "Leishmaniasis, Visceral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 |
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leishmaniasis, Visceral" by people in Profiles.
-
Hypertriglyceridemia: a possible diagnostic marker of disease severity in visceral leishmaniasis. Infection. 2016 Feb; 44(1):39-45.
-
Leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. Hum Immunol. 2013 Dec; 74(12):1575-8.
-
Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases: an experimental evidence. J Vector Borne Dis. 2012 Dec; 49(4):266-7.
-
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial. Trop Med Int Health. 2013 Jan; 18(1):96-100.
-
Usefulness of the direct agglutination test in the early detection of subclinical Leishmania donovani infection: a community-based study. Ann Trop Med Parasitol. 2005 Dec; 99(8):743-9.
-
A randomized clinical trial of low dosage combination of pentamidine and allopurinol in the treatment of antimony unresponsive cases of visceral leishmaniasis. J Assoc Physicians India. 2001 Jun; 49:609-13.
-
Leishmania donovani in blood smears of asymptomatic persons. Acta Trop. 2000 Sep 18; 76(2):195-6.
-
Demonstration of Leishmania parasites in skin lesions of Indian post kala-azar dermal leishmaniasis (PKDL) cases. J Commun Dis. 2000 Mar; 32(1):67-8.